{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:22:11Z","timestamp":1792718531642,"version":"4.5.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T00:00:00Z","timestamp":1418601600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0114457","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T18:47:57Z","timestamp":1418669277000},"page":"e114457","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":64,"title":["Cytotoxic Effects of Tetracycline Analogues (Doxycycline, Minocycline and COL-3) in Acute Myeloid Leukemia HL-60 Cells"],"prefix":"10.1371","volume":"9","author":[{"given":"Hairong","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim R.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5ke","family":"Sid\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Pot\u00e1cov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,12,15]]},"reference":[{"key":"ref1","unstructured":"Swerdlow SH (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer. 439 p."},{"key":"ref2","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Results Program website. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/seer.cancer.gov\/statfacts\/html\/leuks.html\" xlink:type=\"simple\">http:\/\/seer.cancer.gov\/statfacts\/html\/leuks.html<\/ext-link>. Accessed 2014 May 19."},{"key":"ref3","unstructured":"Cancer Research UK, Cancer Stats website. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cancerresearchuk.org\/cancer-info\/cancerstats\" xlink:type=\"simple\">http:\/\/www.cancerresearchuk.org\/cancer-info\/cancerstats<\/ext-link>. Accessed 2014 May 19."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Fletcher A, Whittle A, Bowen D (2011) Epidemiology and Etiology of Leukemias. In: Faderl S, Kantarjian H, editors. Leukemias: Principles and Practice of Therapy. Wiley-Blackwell. pp. 17\u201328.","DOI":"10.1002\/9781444327359.ch2"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bcmd.2012.10.005","article-title":"A historical perspective on the development of the cytarabine (7 days) and daunorubicin (3 days) treatment regimen for acute myelogenous leukemia: 2013 the 40th anniversary of 7+3","volume":"50","author":"MA Lichtman","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2141.2010.08470.x","article-title":"Acute myeloid leukaemia in the elderly: a review","volume":"152","author":"DA Pollyea","year":"2011","journal-title":"Br J Haematol"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Bachur NR (1989) Anthracycline Antibiotics. In: Woolley PV, editor. Cancer Management in Man. Springer Netherlands. pp. 125\u2013130.","DOI":"10.1007\/978-94-009-1095-9_10"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications","volume":"54","author":"AN Sapadin","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"I Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/08959374980120011901","article-title":"Chemical and biological dynamics of tetracyclines","volume":"12","author":"ML Nelson","year":"1998","journal-title":"Advances in dental research"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0145-2126(85)90142-0","article-title":"The antitumour effect of doxycycline on a T-cell leukaemia in the rat","volume":"9","author":"C van den Bogert","year":"1985","journal-title":"Leuk Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ijc.22303","article-title":"Doxycycline induces caspase-dependent apoptosis in human pancreatic cancer cells","volume":"120","author":"PX Mouratidis","year":"2007","journal-title":"International journal of cancer Journal international du cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1006\/bbrc.1999.0929","article-title":"Doxycycline induces Fas\/Fas ligand-mediated apoptosis in Jurkat T lymphocytes","volume":"260","author":"J Liu","year":"1999","journal-title":"Biochemical and biophysical research communications"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/ijc.21447","article-title":"Tetracycline analogues (doxycycline and COL-3) induce caspase-dependent and -independent apoptosis in human colon cancer cells","volume":"118","author":"T Onoda","year":"2006","journal-title":"International journal of cancer Journal international du cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/cdd.2011.96","article-title":"Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012","volume":"19","author":"L Galluzzi","year":"2012","journal-title":"Cell Death Differ"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00005-012-0205-y","article-title":"Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer","volume":"61","author":"W Chaabane","year":"2013","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1038\/sj.onc.1209598","article-title":"Mitochondria as therapeutic targets for cancer chemotherapy","volume":"25","author":"L Galluzzi","year":"2006","journal-title":"Oncogene"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood.V71.1.242.242","article-title":"HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3","volume":"71","author":"WT Dalton Jr","year":"1988","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1182\/blood-2011-12-379008","article-title":"Acute myeloid leukemia in the real world: why population-based registries are needed","volume":"119","author":"G Juliusson","year":"2012","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jmb.2010.02.049","article-title":"Nonantibiotic properties of tetracyclines: structural basis for inhibition of secretory phospholipase A2","volume":"398","author":"D Dalm","year":"2010","journal-title":"Journal of molecular biology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","article-title":"Safety of doxycycline and minocycline: a systematic review","volume":"27","author":"K Smith","year":"2005","journal-title":"Clinical therapeutics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1006588708131","article-title":"Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis","volume":"16","author":"RE Seftor","year":"1998","journal-title":"Clin Exp Metastasis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jnci\/93.3.178","article-title":"Development of matrix metalloproteinase inhibitors in cancer therapy","volume":"93","author":"M Hidalgo","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","article-title":"Matrix metalloproteinases and tumor metastasis","volume":"25","author":"EI Deryugina","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1476-5381.2010.00746.x","article-title":"Activation of c-Jun N-terminal kinase is essential for mitochondrial membrane potential change and apoptosis induced by doxycycline in melanoma cells","volume":"160","author":"JM Shieh","year":"2010","journal-title":"Br J Pharmacol"},{"key":"ref26","first-page":"3283","article-title":"Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis","volume":"46","author":"C van den Bogert","year":"1986","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/sj.bjp.0704068","article-title":"Effects of chemically modified tetracyclines (CMTs) in sensitive, multidrug resistant and apoptosis resistant leukaemia cell lines","volume":"133","author":"M Tolomeo","year":"2001","journal-title":"Br J Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1073\/pnas.82.3.790","article-title":"Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells","volume":"82","author":"D Wolf","year":"1985","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2184.1991.tb01150.x","article-title":"Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli","volume":"24","author":"SV Lennon","year":"1991","journal-title":"Cell proliferation"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lab.2003.12.012","article-title":"Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells","volume":"143","author":"T Onoda","year":"2004","journal-title":"J Lab Clin Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.10168","article-title":"Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model","volume":"98","author":"BL Lokeshwar","year":"2002","journal-title":"International journal of cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ygyno.2012.01.006","article-title":"Minocycline inhibits growth of epithelial ovarian cancer","volume":"125","author":"MH Pourgholami","year":"2012","journal-title":"Gynecol Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1749-6632.1999.tb07760.x","article-title":"CMT-3, a chemically modified tetracycline, inhibits bony metastases and delays the development of paraplegia in a rat model of prostate cancer","volume":"878","author":"MG Selzer","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1749-6632.1999.tb07690.x","article-title":"MMP inhibition in prostate cancer","volume":"878","author":"BL Lokeshwar","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1590\/S0100-879X2006005000109","article-title":"A mechanistic view of mitochondrial death decision pores","volume":"40","author":"JE Belizario","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/emboj.2010.43","article-title":"AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX","volume":"29","author":"C Artus","year":"2010","journal-title":"The EMBO journal"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.taap.2004.11.006","article-title":"Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review","volume":"206","author":"W Xue","year":"2005","journal-title":"Toxicology and applied pharmacology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/djn517","article-title":"The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registries","volume":"101","author":"N Howlader","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0145-2126(93)90068-V","article-title":"Expression of differentially phosphorylated Rb and mutant p53 proteins in myeloid leukemia cell lines","volume":"17","author":"S Sen","year":"1993","journal-title":"Leuk Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/02841860152619098","article-title":"Role of retinoblastoma tumor suppressor protein in DNA damage response","volume":"40","author":"JY Wang","year":"2001","journal-title":"Acta Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1101\/gad.211326.112","article-title":"The retinoblastoma protein induces apoptosis directly at the mitochondria","volume":"27","author":"KI Hilgendorf","year":"2013","journal-title":"Genes Dev"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/187152010793498645","article-title":"Doxycycline in mitochondrial mediated pathway of apoptosis: a systematic review","volume":"10","author":"J Sagar","year":"2010","journal-title":"Anti-cancer agents in medicinal chemistry"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4161\/pri.3.2.8820","article-title":"Minocycline as a potential therapeutic agent in neurodegenerative disorders characterised by protein misfolding","volume":"3","author":"W Noble","year":"2009","journal-title":"Prion"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1158\/1078-0432.CCR-04-0804","article-title":"A phase I and pharmacokinetic study of Col-3 (Metastat), an oral tetracycline derivative with potent matrix metalloproteinase and antitumor properties","volume":"10","author":"S Syed","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2005.04.2614","article-title":"Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi\u2019s sarcoma: an AIDS Malignancy Consortium Study","volume":"24","author":"BJ Dezube","year":"2006","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0114457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T23:17:52Z","timestamp":1598570272000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0114457"}},"subtitle":[],"editor":[{"given":"Zhengqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,15]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0114457","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,15]]}}}